Showing results (101-110 of 204) with videos related to

Sort By:
Pageof 21
The British Journal of Radiology|July 13, 2019
Normal values and test-retest variability of stimulated-echo diffusion tensor imaging and fat fraction measurements in the muscleMatthew Farrow, Andrew J Grainger, Ai Lyn Tan, et al.
Arthritis and Rheumatism|May 28, 2011
B cell biomarkers of rituximab responses in systemic lupus erythematosusEdward M Vital, Shouvik Dass, Maya H Buch, et al.
Annals of the Rheumatic Diseases|January 31, 2020
Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trialPaul Emery, Sarah Horton, Raluca Bianca Dumitru, et al.
Nature Reviews. Rheumatology|January 12, 2024
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinicianZoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, et al.
Rheumatology (Oxford, England)|September 11, 2021
Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritisGerd R Burmester, Vivian P Bykerk, Maya H Buch, et al.
Clinical and Experimental Rheumatology|June 19, 2012
Multiplexing immunoassays for cytokine detection in the serum of patients with rheumatoid arthritis: lack of sensitivity and interference by rheumatoid factorSarah M Churchman, Janina Geiler, Rekha Parmar, et al.
The American Journal of Cardiology|January 25, 2011
Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularizationTarun Chakravarty, Mamta H Buch, Hursh Naik, et al.
Rheumatology (Oxford, England)|July 29, 2008
The value of synovial cytokine expression in predicting the clinical response to TNF antagonist therapy (infliximab)M H Buch, R J Reece, M A Quinn, et al.
Rheumatology (Oxford, England)|August 12, 2025
Risk of venous thromboembolism in people with rheumatoid arthritis: a population-based study in the UKMark D Russell, Katie Bechman, Mark Gibson, et al.
Health Technology Assessment (Winchester, England)|June 15, 2018
Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCTSarah Brown, Colin C Everett, Kamran Naraghi, et al.
Pageof 21